TY  - CONF

T1  - Laboratory safety of dupilumab in paediatric patients aged >= 6 to < 12 years with severe atopic dermatitis: results from a phase III trial (LIBERTY AD PEDS)

JO  - BRITISH JOURNAL OF DERMATOLOGY

PY  - 2021/01/01

AU  - Wollenberg A

AU  - Thaci D

AU  - Cork MJ

AU  - Arkwright PD

AU  - Gooderham M

AU  - Sun X

AU  - Vakil J

AU  - Khokhar FA

ED  - 

VL  - 185

IS  - 3

SP  - E122

EP  - E123

Y2  - 2024/10/23

ER  -